Woodline Partners’s Pardes Biosciences PRDS Stock Holding History
Bought
Maintained
Sold
Other funds holding PRDS
JCM
C
Woodline Partners's PRDS Position: Q4 2021 in Review
Woodline Partners sold out of Pardes Biosciences (PRDS) in Q4 2021, closing a stake of 238,804 shares — an estimated $2.38M sold.
Woodline Partners first reported a position in PRDS in Q1 2021 and held it in 3 quarters. The position peaked at $2.38M in Q3 2021. 41 funds tracked by Wall St. Rank hold PRDS as of Q4 2021.
- Woodline Partners reported no remaining Pardes Biosciences position as of Q4 2021 after selling out during the quarter.
- Woodline Partners sold 238,804 Pardes Biosciences shares in Q4 2021, an estimated $2.38M.
- Woodline Partners first reported a position in Pardes Biosciences in Q1 2021 and held it in 3 quarters.
- Woodline Partners's Pardes Biosciences position peaked at $2.38M in Q3 2021.
- 41 funds tracked by Wall St. Rank held Pardes Biosciences as of Q4 2021.
Based on Woodline Partners's 13F filing for Q4 2021, filed 14 Feb 2022.